经皮冠状动脉介入治疗术后急性支架内血栓形成原因及治疗策略解析1例
杨敏,张阔,袁勋,王文尧,张璇,吕纳强,张茵,陈珏,唐熠达
摘要(Abstract)：
<正>急性支架内血栓形成是经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)的严重并发症之一,虽然发生率并不高,但是具有发病急,预后不良等特点。本文将报道1例典型的急性支架内血栓病例,并对其形成原因及治疗策略进行解析。1临床资料患者女,56岁。胸痛病史3年,加重1个月,于当地医院诊断为"冠心病",予以阿司匹林100 mg/次、每日1次,硫酸
关键词(KeyWords)： 急性支架内血栓;氯吡格雷低反应;血小板功能检测
基金项目(Foundation):
作者(Author): 杨敏,张阔,袁勋,王文尧,张璇,吕纳强,张茵,陈珏,唐熠达
参考文献(References)：
- [1]D'Ascenzo F,Bollati M,Clementi F,et al.Incidence and predictors of coronary stent thrombosis:evidence from an international collaborative meta-analysis including 30 studies,221,066 patients,and 4276 thromboses.Int J Cardiol,2013,167:575-584.
- [2]张燕,任艺虹,周超飞,等.经皮冠状动脉介入治疗术后急性、亚急性支架内血栓形成的危险因素分析.中国循环杂志,2013,28:17-20.
- [3]Hobson AR,Qureshi Z,Banks P.Gender and responses to aspirin and clopidogrel:insights using short thrombelastography.Cardiovasc Therapy,2009,27:246-252.
- [4]刘然,师树田,索旻,等.对氯吡格雷低反应患者换用替格瑞洛后的有效性与安全性评价.中国介入心脏病学杂志,2014,22:12-17.
- [5]Steg PG,James S,Harrington RA,et al.Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention:A Platelet Inhibition and Patient Outcomes(PLATO)trial subgroup analysis.Circulation,2010,12:2131-2141.
- [6]Storey RF,Angiolillo DJ,Patil SB,et al.Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes:the PLATO(PLATelet inhibition and patient Outcomes)PLATELET substudy.J Am Coll Cardiol,2010,56:1456-1462.